Suchergebnisse - "Criscuolo, Clelia"

PubPharm (5)

1

Epigenetic challenges on the horizon of chimeric antigen receptor-T

enthalten in: Cytotherapy | 2024

von Benincasa, G. | Strozziero, M. | Di Pastena, M. | +4

2

Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma : Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials

enthalten in: Hematological oncology | 2022

von Bruzzese, A. | Derudas, D. | Galli, M. | +57

3

Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma : Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials

enthalten in: Hematological Oncology | 2022

von Bruzzese, A. | Derudas, D. | Galli, M. | +57

4

Immune reactivity during COVID-19 : Implications for treatment

enthalten in: Immunology letters | 2021

von Napoli, C. | Benincasa, G. | Criscuolo, C. | +3

5

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma : Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

enthalten in: Haematologica | 2021

von Gentile, M. | Specchia, G. | Derudas, D. | +53

1
[1]